An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Dana Drzayich Antol
Adrianne Waldman Casebeer
Richard W. DeClue
Stephen Stemkowski
Patricia A. Russo
机构：
[1] Comprehensive Health Insights,
[2] Novartis Pharmaceuticals Corporation,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Cardiology; Dyspnea; Ejection fraction; Fatigue; Heart failure; Hospitalization; Sacubitril/valsartan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：785 / 795
页数：10
相关论文
共 50 条
  • [31] Sacubitril/Valsartan in heart failure with reduced ejection fraction: clinical and echocardiographic insights from a real world population
    Valli, F.
    Bursi, F.
    Santangelo, G.
    Toriello, F.
    Rusconi, I.
    Mondellini, G.
    Vella, A. M.
    Faggiano, A.
    Persampieri, S.
    Carugo, S.
    Guazzi, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 785 - 785
  • [32] The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Martens, Pieter
    Belien, Hanne
    Dupont, Matthias
    Vandervoort, Pieter
    Mullens, Wilfried
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (04)
  • [33] Cause and duration of heart failure may impact on the response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Mandal, Amit K. J.
    Missouris, Constantinos G.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 233 - 234
  • [34] The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Martens, P. Pieter
    Belien, H.
    Dupont, M.
    Mullens, W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 256 - 256
  • [35] Electrocardiographic predictors of response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Shpigelman, Jonathan
    Blaine, Ciara
    Nugent, Carol-Ann
    Kiernan, Louise
    Cahir, Caitriona
    Mac Curtain, Benjamin
    Bachari, Amir
    Irfan, Wadeed
    O'Boyle, Patrick
    O'Neill, James
    Daly, Michael
    JOURNAL OF ELECTROCARDIOLOGY, 2024, 84 : 104 - 108
  • [36] Comparative effectiveness of sacubitril/valsartan versus angiotensin receptor blockers in patients with heart failure with preserved ejection fraction: A real-world study
    Riaz, Munaza
    Smith, Steven M.
    Dietrich, Eric A.
    Winchester, David E.
    Guo, Jingchuan
    Park, Haesuk
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (14) : 599 - 607
  • [37] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting (vol 7, pg 1049, 2020)
    Backelin, C. Nordberg
    Fu, M.
    Ljungman, C.
    ESC HEART FAILURE, 2025, 12 (02): : 1525 - 1525
  • [38] The PARASAIL study-Patient Reported Outcomes from the Canadian Real World Experience use of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction
    Haddad, Haissam
    Bergeron, Sebastien
    Ignaszewski, Andrew
    Searles, Gregory
    Rochdi, Driss
    Bastien, Natacha
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S55 - S56
  • [39] Early effects of Sacubitril/valsartan on exercise tolerance in patients with heart failure with reduced ejection fraction.
    Vitale, G.
    Sarullo, S.
    Nugara, C.
    Maria Sarullo, F. M. Filippo
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 240 - 241
  • [40] Dapagliflozin in Heart Failure with Reduced Ejection Fraction: A Real-World Study
    Hao, Zhengyang
    Zhang, Yanzhou
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 6 (04) : 219 - 223
12345